SignaLink3: a multi-layered resource to uncover tissue-specific signaling networks.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
07 01 2022
Historique:
accepted: 22 09 2021
revised: 16 09 2021
received: 15 08 2021
pubmed: 12 10 2021
medline: 24 2 2022
entrez: 11 10 2021
Statut: ppublish

Résumé

Signaling networks represent the molecular mechanisms controlling a cell's response to various internal or external stimuli. Most currently available signaling databases contain only a part of the complex network of intertwining pathways, leaving out key interactions or processes. Hence, we have developed SignaLink3 (http://signalink.org/), a value-added knowledge-base that provides manually curated data on signaling pathways and integrated data from several types of databases (interaction, regulation, localisation, disease, etc.) for humans, and three major animal model organisms. SignaLink3 contains over 400 000 newly added human protein-protein interactions resulting in a total of 700 000 interactions for Homo sapiens, making it one of the largest integrated signaling network resources. Next to H. sapiens, SignaLink3 is the only current signaling network resource to provide regulatory information for the model species Caenorhabditis elegans and Danio rerio, and the largest resource for Drosophila melanogaster. Compared to previous versions, we have integrated gene expression data as well as subcellular localization of the interactors, therefore uniquely allowing tissue-, or compartment-specific pathway interaction analysis to create more accurate models. Data is freely available for download in widely used formats, including CSV, PSI-MI TAB or SQL.

Identifiants

pubmed: 34634810
pii: 6389625
doi: 10.1093/nar/gkab909
pmc: PMC8728204
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D701-D709

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S50743X/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M011216/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/CCG1720/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R012490/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10353
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/T/000PR9814
Pays : United Kingdom
Organisme : European Research Council
ID : 694679
Pays : International
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/T/000PR9817
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10355
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/T/000PR9819
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162
pubmed: 30423142
Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
Bioinformatics. 2018 Jul 15;34(14):2441-2448
pubmed: 29547932
Annu Rev Biochem. 2004;73:1051-87
pubmed: 15189167
J Biomed Semantics. 2014 May 19;5:21
pubmed: 25009735
Nat Biotechnol. 2005 Aug;23(8):951-9
pubmed: 16082366
Nucleic Acids Res. 2019 Jan 8;47(D1):D529-D541
pubmed: 30476227
Nucleic Acids Res. 2009 Jan;37(Database issue):D105-10
pubmed: 18996891
Zebrafish. 2016 Dec;13(6):541-544
pubmed: 27097230
Nucleic Acids Res. 2013 Jan;41(Database issue):D1228-33
pubmed: 23180781
Integr Biol (Camb). 2015 Aug;7(8):904-20
pubmed: 25932872
Mol Syst Biol. 2021 Mar;17(3):e9923
pubmed: 33749993
Nucleic Acids Res. 2014 Jan;42(Database issue):D472-7
pubmed: 24243840
Methods Mol Biol. 2018;1819:53-73
pubmed: 30421399
BMC Syst Biol. 2013 Jan 18;7:7
pubmed: 23331499
Cell Death Differ. 2012 Sep;19(9):1571
pubmed: 22743998
Nucleic Acids Res. 2021 Jan 8;49(D1):D899-D907
pubmed: 33219682
PLoS Comput Biol. 2014 Feb 13;10(2):e1003385
pubmed: 24550716
Mol Cell Proteomics. 2009 Sep;8(9):2063-70
pubmed: 19502588
Nat Rev Genet. 2003 Jan;4(1):39-49
pubmed: 12509752
Nucleic Acids Res. 2014 Jan;42(Database issue):D358-63
pubmed: 24234451
Nat Biotechnol. 2010 Sep;28(9):935-42
pubmed: 20829833
Cir Cir. 2015 Mar-Apr;83(2):165-74
pubmed: 25986976
Genome Biol. 2015 Feb 26;16:45
pubmed: 25887147
Nucleic Acids Res. 2009 Jan;37(Database issue):D98-104
pubmed: 18927107
Nucleic Acids Res. 2020 Jan 8;48(D1):D762-D767
pubmed: 31642470
RNA. 2006 Feb;12(2):192-7
pubmed: 16373484
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891
pubmed: 33137190
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Sci Signal. 2011 May 17;4(173):pt3
pubmed: 21586727
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7
pubmed: 26656494
Nucleic Acids Res. 2021 Jan 8;49(D1):D212-D220
pubmed: 33106848
Nucleic Acids Res. 2020 Jan 8;48(D1):D504-D510
pubmed: 31665520
Pharmacol Ther. 2013 Jun;138(3):333-408
pubmed: 23384594
Bioinformatics. 2019 Oct 1;35(19):3779-3785
pubmed: 30793173
PLoS One. 2011 May 03;6(5):e19240
pubmed: 21559328
Nucleic Acids Res. 2021 Jan 8;49(D1):D939-D946
pubmed: 33152070
Nucleic Acids Res. 2019 Jan 8;47(D1):D867-D873
pubmed: 30407545
Nucleic Acids Res. 2015 Jan;43(Database issue):D485-93
pubmed: 25348397
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
Bioinformatics. 2010 Aug 15;26(16):2042-50
pubmed: 20542890
Nat Methods. 2014 Jan;11(1):94-9
pubmed: 24240319
Nucleic Acids Res. 2020 Jan 8;48(D1):D160-D165
pubmed: 31670377
J Genet Genomics. 2017 May 20;44(5):265-268
pubmed: 28529080
Trends Cell Biol. 2010 Jan;20(1):2-4
pubmed: 20005715

Auteurs

Luca Csabai (L)

Earlham Institute, Norwich NR4 7UZ, UK.
Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Dávid Fazekas (D)

Earlham Institute, Norwich NR4 7UZ, UK.
Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Tamás Kadlecsik (T)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Máté Szalay-Bekő (M)

Earlham Institute, Norwich NR4 7UZ, UK.

Balázs Bohár (B)

Earlham Institute, Norwich NR4 7UZ, UK.
Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Matthew Madgwick (M)

Earlham Institute, Norwich NR4 7UZ, UK.
Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.

Dezső Módos (D)

Earlham Institute, Norwich NR4 7UZ, UK.
Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.

Márton Ölbei (M)

Earlham Institute, Norwich NR4 7UZ, UK.
Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.

Lejla Gul (L)

Earlham Institute, Norwich NR4 7UZ, UK.

Padhmanand Sudhakar (P)

Earlham Institute, Norwich NR4 7UZ, UK.
Translational Research in GastroIntestinal Disorders, Leuven BE-3000, Belgium.

János Kubisch (J)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Oyebode James Oyeyemi (OJ)

Zeekay Institute of Advanced and Professional Studies, Lagos, Nigeria.

Orsolya Liska (O)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
HCEMM-BRC Metabolic Systems Biology Lab, Szeged H-6726, Hungary.
Synthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre, Eötvös Loránd Research Network (ELKH), Szeged H-6726, Hungary.
Doctoral School in Biology, University of Szeged, Szeged H-6720 Hungary.

Eszter Ari (E)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
HCEMM-BRC Metabolic Systems Biology Lab, Szeged H-6726, Hungary.
Synthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre, Eötvös Loránd Research Network (ELKH), Szeged H-6726, Hungary.

Bernadette Hotzi (B)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Viktor A Billes (VA)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
ELKH/MTA-ELTE Genetics Research Group, Budapest H-1117, Hungary.

Eszter Molnár (E)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

László Földvári-Nagy (L)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
Department of Morphology and Physiology, Semmelweis University, Budapest H-1088, Hungary.

Kitti Csályi (K)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Amanda Demeter (A)

Earlham Institute, Norwich NR4 7UZ, UK.
Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Nóra Pápai (N)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
Institute of Molecular Biotechnology, Vienna A-1030, Austria.

Mihály Koltai (M)

Centre for the Mathematical Modelling of Infectious Diseases (CMMID), London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Máté Varga (M)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.

Katalin Lenti (K)

Department of Morphology and Physiology, Semmelweis University, Budapest H-1088, Hungary.

Illés J Farkas (IJ)

Citibank Europe plc Hungarian Branch Office, Budapest H-1133, Hungary.

Dénes Türei (D)

Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.

Péter Csermely (P)

Department of Molecular Biology, Semmelweis University, Budapest H-1094, Hungary.

Tibor Vellai (T)

Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
ELKH/MTA-ELTE Genetics Research Group, Budapest H-1117, Hungary.

Tamás Korcsmáros (T)

Earlham Institute, Norwich NR4 7UZ, UK.
Department of Genetics, ELTE Eötvös Loránd University, Budapest H-1117, Hungary.
Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH